O'Brien Brandon's Form 4/A amendment
AmendedCorvel Corp (CRVL) · filed Aug 21, 2024
- Accession no.
- 0000950170-24-099532
- Filed
- Aug 21, 2024
- Trade date
- Aug 1-19, 2024
- Filing delay
- 20 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 5, 2024
This filing lists 16 non-derivative transactions and 5 derivative transactions. Open-market sales total $157.4K. It was filed 20 days after the trade.
This amendment replaces 0001754499-24-000012 (filed Aug 5, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Brien BrandonCIK 0001754499 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Common Stock | MOption exerciseAcquired | +500 | $87.69 | +$43,845 | 7,805 | Direct | |
| Aug 1, 2024 | Common Stock | FTax withholdingDisposed | −142 | $306.82 | −$43,568.44 | 7,663 | Direct | |
| Aug 1, 2024 | Common Stock | FTax withholdingDisposed | −161 | $306.82 | −$49,398.02 | 7,502 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseAcquired | +400 | $87.69 | +$35,076 | 7,902 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseAcquired | +13 | $119.48 | +$1,553.24 | 7,915 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseAcquired | +62 | $79.49 | +$4,928.38 | 7,977 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseAcquired | +25 | $52.69 | +$1,317.25 | 8,002 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −15 | $316.45 | −$4,746.75 | 7,987 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −144 | $316.26 | −$45,541.44 | 7,843 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −84 | $314.95 | −$26,455.8 | 7,759 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −6 | $314.95 | −$1,889.7 | 7,753 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −3 | $314.94 | −$944.82 | 7,750 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −80 | $314.66 | −$25,172.8 | 7,670 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −5 | $314.63 | −$1,573.15 | 7,665 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −6 | $314.34 | −$1,886.04 | 7,659 | Direct | |
| Aug 19, 2024 | Common Stock | SSaleDisposed | −157 | $313.25 | −$49,180.25 | 7,502 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 1,800 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseDisposed | −25 | $0.00 | $0 | 0 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseDisposed | −62 | $0.00 | $0 | 0 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 1,400 | Direct | |
| Aug 2, 2024 | Common Stock | MOption exerciseDisposed | −13 | $0.00 | $0 | 737 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On August 5, 2024, the Reporting Person filed a Form 4 reporting (i) the exercise of nonqualified stock options on August 1, 2024 and August 2, 2024, (ii) subsequent open-market sale transactions on August 1, 2024, and (iii) subsequent open-market sale transactions on August 2, 2024 that did not occur until August 19, 2024 due to an administrative error. This amendment is being filed to correct the transaction dates and sale prices.
- F2
Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise.
- F3
Option will vest based on achievement of certain performance criteria relating to earnings growth.
- F4
Exercisable as to 25% of shares one year following the grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.